Novel fidaxomicin antibiotics through site-selective catalysis
Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moi...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c32e82beff5d448d939c9d14cc5a1314 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c32e82beff5d448d939c9d14cc5a1314 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c32e82beff5d448d939c9d14cc5a13142021-12-02T17:01:35ZNovel fidaxomicin antibiotics through site-selective catalysis10.1038/s42004-021-00501-62399-3669https://doaj.org/article/c32e82beff5d448d939c9d14cc5a13142021-05-01T00:00:00Zhttps://doi.org/10.1038/s42004-021-00501-6https://doaj.org/toc/2399-3669Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moieties.David DaillerAndrea DorstDaniel SchäflePeter SanderKarl GademannNature PortfolioarticleChemistryQD1-999ENCommunications Chemistry, Vol 4, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Chemistry QD1-999 |
spellingShingle |
Chemistry QD1-999 David Dailler Andrea Dorst Daniel Schäfle Peter Sander Karl Gademann Novel fidaxomicin antibiotics through site-selective catalysis |
description |
Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moieties. |
format |
article |
author |
David Dailler Andrea Dorst Daniel Schäfle Peter Sander Karl Gademann |
author_facet |
David Dailler Andrea Dorst Daniel Schäfle Peter Sander Karl Gademann |
author_sort |
David Dailler |
title |
Novel fidaxomicin antibiotics through site-selective catalysis |
title_short |
Novel fidaxomicin antibiotics through site-selective catalysis |
title_full |
Novel fidaxomicin antibiotics through site-selective catalysis |
title_fullStr |
Novel fidaxomicin antibiotics through site-selective catalysis |
title_full_unstemmed |
Novel fidaxomicin antibiotics through site-selective catalysis |
title_sort |
novel fidaxomicin antibiotics through site-selective catalysis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/c32e82beff5d448d939c9d14cc5a1314 |
work_keys_str_mv |
AT daviddailler novelfidaxomicinantibioticsthroughsiteselectivecatalysis AT andreadorst novelfidaxomicinantibioticsthroughsiteselectivecatalysis AT danielschafle novelfidaxomicinantibioticsthroughsiteselectivecatalysis AT petersander novelfidaxomicinantibioticsthroughsiteselectivecatalysis AT karlgademann novelfidaxomicinantibioticsthroughsiteselectivecatalysis |
_version_ |
1718382109321592832 |